Long term stability of HBsAg, anti-HBc and anti-HCV in dried blood spot samples and eluates

Journal of Clinical Virology

Volumn 71, Issue , 2015, Pages 10-17

  McAllister, Georgina ^a   Shepherd, Samantha ^b   Templeton, Kate ^a   Aitken, Celia ^b   Gunson, Rory ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Dried blood spots; Eluates; Hepatitis B; Hepatitis C; Storage

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIGEN; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY;

ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; FREEZING; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; STORAGE TEMPERATURE; THERMOSTABILITY; DESICCATION; EVALUATION STUDY; HEPATITIS B; HEPATITIS D; LABORATORY DIAGNOSIS; PROCEDURES; PROTEIN STABILITY; SENSITIVITY AND SPECIFICITY; SEROLOGY; TEMPERATURE; TIME FACTOR;

DESICCATION; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HEPATITIS D; HUMANS; PROTEIN STABILITY; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS;

EID: 84941552715     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.07.303     Document Type: Article

References (30)

1. Guthrie R., Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Paediatrics 1963, 32:338-343.
2. Snijdewind I.J.M., van Kampen J.J.A., Fraaij P.L.A., van der Ende M.E., Osterhaus A.D., Gruters R.A. Current and future applications of dried blood spots in viral disease management. Antivir. Res. 2012 2012, 93(3):309-321.
3. Smit P.W., Sollis K.A., Fiscus S., Ford N., Vitoria M., et al. Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS ONE 2014, 9(3):6. 10.1371/journal.pone.0086461.
4. Johannessen A. Dried blood spots in HIV monitoring: applications in resource-limited settings. Bioanal 2010, 2(11):1893-1908. 10.4155/bio.10.120.
5. Martin N.K., Hickman M., Miners A., Hutchinson S.J., Taylor A., Vickerman P. Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons. BMJ Open 2013, 3. 10.1136/bmjopen-2013-003153.
6. Abdou-Saleh M., Davis P., Rice P., Checinski K., Drummond C., Maxwell D., Godfrey C., John C., Corrin B., Tibbs C., Oyefeso A., de Ruiter M., Ghodse H. The effectiveness of behavioural interventions in the primary prevention of Hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned. Harm Reduct. J. 2008, 5:25. 10.1186/1477-7517-5-25.
7. Hickman M., McDonald T., Judd A., Nichols T., Hope V., Skidmore S., Parry J.V. Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial. J. Viral. Hepat. 2008, 15(4):250-254.
8. Craine N., Parry J., O'Toole J., D'Arcy S., Lyons M. Improving blood-borne viral diagnostics: clinical audit of the uptake of dried blood spot testing offered by a substance misuse service. J. J. Viral. Hepat. 2009, 16(3):219-222. 10.1111/j.1365-2893.2008.01061.x.
9. Jones L., Bates G., McCoy E., Benynon C., MvVeigh J., Bellis M. A Systematic Review of the Effectiveness & Cost-effectiveness of Interventions Aimed at Raising Awareness and Engaging with Groups Who Are at an Increased Risk of Hepatitis B and C infection 2012, Centre for Public Health, Liverpool John Moores University, Available from: http://www.nice.org.uk/nicemedia/live/11957/5946/5946.pdf (accessed 03.12.13).
10. Palmateer N., Allen E., Taylor A., Hutchinson S., Goldberg D. Application of a novel method to estimate incidence of hepatitis C among injecting drug users in Scotland. J. Epidemiol. Community Health 2011, 65(1):A70-A79. http://dx.doi.org/10.1136/jech.2011.142976c.3.
11. Allen E.J., Palmateer N.E., Hutchinson S.J., Cameron S., Goldberg D.J., Taylor A. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland. Int. J. Drug Policy 2012, 23(5):346-352. 10.1016/j.drugpo.2012.07.006.
12. Palmateer N., Hutchinson S., McAllister G., Munro A., Cameron S., Goldberg D., Taylor A. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. J. Viral. Hepat. 2013, 21(1):25-32. 10.1111/jvh.12117.
13. Palmateer N.E., Taylor A., Goldberg D.J., Munro A., Aitken C., Shepherd S.J., McAllister G., Gunson R., Hutchinson S.J. Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions. PLoS One 2014, 11(9):8. 10.1371/journal.pone.0104515.
14. Corran P.H., Cook J., Lynch C., Leendertse H., Manjurano A., Griffin J., Cox J., Abeku T., Bousema T., Ghani A.C., Drakeley C., Riley Eleanor Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar. J. 2008, 7:195.
15. Behets F., Kashamuka M., Pappaioanou M., Green T.A., Ryder R.W., Batter V., George J.R., Hannon H., Quinn T.C. Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J. Clin. Microbiol. 1992, 30(5):1179-1182.
16. Marques B.L., Brandäo C.U., Silva E.F., Marques V.A., Villela-Noqueira C.A., Do Ó K.M., de Paula M.T., Lewis-Ximenez L.L., Lampe E., Villar L.M. Dried blood spot samples: optimisation of commercial EIAs for hepatitis C antibody detection and stability under different storage conditions. J. Med. Virol. 2012, 84(10):1600-1607.
17. Brandão C.P.U., Marques B.L.C., Marques V.A., Villela-Nogueira C.A., Do O.K.M.R., de Paula M.T., Lewis-Ximenez L.L., Lampe E., Sá Ferreira J.A., Villar L.M. Simultaneous detection of hepatitis C virus antigen and antibodies in dried blood spots. J. Clin. Virol. 2013, 57(2):98-102.
18. Tuaillon E., Mondain A.-E., Meroueh F., Ottomani L., Picot M.-C., Nagot N., Van de Perre P., Ducos J. Dried blood spots for hepatitis C virus serology and molecular testing. Hepatology 2010, 51(3):752-758.
19. Bennett S., Gunson R.N., McAllister G.E., Hutchinson S.J., Goldberg D.J., Cameron S.O., Carman W.F. Detection of hepatitis C virus RNA in dried blood spots. J. Clin. Virol. 2012, 54(2):106-109.
20. Greenman J., Roberts T., Cohn J., Messac L. Dried blood spot in the genotyping, quantification and storage of HCV RNA: a systematic literature review. J. Viral. Hepat. 2014, 22(4):353-361. 10.1111/jvh.12345.
21. Villar L.M., Correia de Oliveira, Cruz H.M., Yoshida C.F.T., Lampe E., Lewis-Ximenez L.L. Assessment of dried blood spot samples as a simple method for detection of hepatitis B virus markers. J. Med. Virol. 2011, 83:1522-1529.
22. Mendy M., Kirk G.D., van der Sande M., Jeng-Barry A., Lesi O.A., Hainaut P., Sam O., McConkey S., White H. Hepatitis B surface antigenaemia and alpha-foetoprotein detection from dried blood spots: applications to field based studies and to clinical care in hepatitis B virus endemic areas. J. Viral Hepat. 2005, 12:642-647.
23. Hearps A.C., Ryan C.E., Morris L.M., Plate M.M., Greengrass V., Crowe S.M. Stability of dried blood spots for HIV-1 drug resistance analysis. Curr. HIV Res. 2010, 8(2):134-140.
24. Yassin Y.E.M., Eldaif W.A., Elkhider I.E. Evaluation of dry blood spot (DBS) stored at different temperature for detection of HIV antibodies by using different rapid tests. S12 2013, 2:S2-S12. http://dx.doi.org/10.4172/2161-1076.
25. Judd A., Parry J., Hickman M., McDonald T., Jordan L., Lewis K., Contreras M., Dusheiko G., Foster G., Gill N., Kemp K., Main J., Murray-Lyon I., Nelson M. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J. Med. Virol. 2003, 71(1):49-55.
26. Core Team R. R: A language and environment for statistical computing 2015, R Foundation for Statistical Computing, Vienna, Austria, [Internet]. Available from: http://www.R-project.org/ (accessed 03.01.15).
27. Pontisso P., Vidalino L., Quarta S., Gatta A. Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun. Rev. 2008, 8(1):13-17.
28. Bertagnolio S., Derdelinckx I., Parker M., Fitzgibbon J., Fleury H., Peeters M., Schuurman R., Pillay D., Morris L., Tanuri A., Gershy-Damet G.-M., Nkengasong J., Gilks C.F., Sutherland D., Sandstrom P. World Health Organization/HIVResNet drug resistance laboratory strategy. Antivir. Ther. 2008, 13(2):49-57.
29. Skogstrand K., Thorsen P., Nørgaard-Pedersen B., Schendel D.E., Sørensen L.C., Hougaard D.M. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin. Chem. 2005, 51:1854-1866.
30. Duncombe L., Commander N.J., Erdenlig S., McGiven J.A., Stacka J. Investigating the use of protein saver cards for storage and subsequent detection of bovine anti-Brucella abortus smooth lipopolysaccharide antibodies and gamma interferon. Clin. Vaccine Immunol. 2013, 20(11):1669-1674.